Neurology:睡眠时间超八小时更易脑中风?

2015-03-03 林菲菲 “医学界杂志”微信号

有句话说“吃洋参、不如睡五更”,但近日一项来自剑桥大学的研究提示,“睡五更”(10个小时)也许是一种不健康的生活方式。 研究表明,夜间睡眠时长超过8小时的人,将面临更高的脑卒中风险,该研究于2月25日在线发表于Neurology。 研究共纳入9692名年龄在42-81岁的调查对象,进行为期9.5年的前瞻性队列研究,记录调查对象的睡眠模式和脑卒中的发病情况。同时,对Ovid Medlin

有句话说“吃洋参、不如睡五更”,但近日一项来自剑桥大学的研究提示,“睡五更”(10个小时)也许是一种不健康的生活方式。

研究表明,夜间睡眠时长超过8小时的人,将面临更高的脑卒中风险,该研究于2月25日在线发表于Neurology。

研究共纳入9692名年龄在42-81岁的调查对象,进行为期9.5年的前瞻性队列研究,记录调查对象的睡眠模式和脑卒中的发病情况。同时,对Ovid Medline、EMBASE、Cochrane Library数据库中的相关文献进行meta分析。

结果发现,在调整了常规的心脑血管疾病危险因素后,长时间睡眠,即超过8小时睡眠的人群中,发生脑卒中的风险增加46%。其中长期维持长时间睡眠者脑卒中风险更高,是维持平均睡眠时长者的2倍。

Meta分析显示,在小于6小时睡眠的人群中,脑卒中风险增加15%--看到这里,熬夜党们是不是乐坏了?少睡真的比睡过头好?遗憾的是,研究结果还显示,睡眠模式不稳定的人,脑卒中风险骤增,是维持6-8小时睡眠者的4倍!这里的睡眠模式改变指在4年中,从少于6小时睡眠时长跳转到大于8小时睡眠时长。研究中,睡眠模式改变主要发生在老年人群中(小编按:那些平时熬夜加班,周末狂睡不起的人,也许同样需要注意了哈)。

研究人员Leng表示,目前他们还不认为长时间睡眠是导致脑卒中的原因,但前者是脑卒中风险增加的一个信号。医生们通过询问病人的睡眠时长,以及在近几年中睡眠时长是否发生改变,可进一步确认病人发生中风的风险,如睡眠时长从5-6小时跳转到9-10小时者,尤其是在老年人群中,即使血压等指标控制良好者,仍是需要警惕的高危人群。

此前已有不少研究提示睡眠时长和脑卒中之间的关联,但目前研究人员还无法就这一结果给出解释。睡眠会影响体内激素分泌的水平,进而影响血压,不过,当研究组控制了血压因素后,发现睡眠时长和脑卒中之间的关系依旧存在。此前Leng的一项研究发现,习惯午睡的人群中,血清中的C反应蛋白(一种炎症、免疫相关蛋白)偏高,提示睡眠模式会影响免疫系统的反应。

值得一提的是,这是位中国学子在剑桥做的研究,文章第一作者Leng已就睡眠相关问题发表多篇SCI。看到这里,你是不是跃跃欲试了?科研并非都是严肃的实验,好玩的、贴近生活的问题,往往也是很好的科研课题。不过,忙于科研和临床的同时,别忘了保证健康的睡眠模式哈。

原始出处:


Leng Y1, Cappuccio FP2, Wainwright NW2, Surtees PG2, Luben R2, Brayne C2, Khaw KT2.Sleep duration and risk of fatal and nonfatal stroke: A prospective study and meta-analysis.Neurology. 2015 Feb 25. pii: 10.1212/WNL.0000000000001371. [Epub ahead of print]

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1999508, encodeId=199e199950825, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Mon Apr 13 01:26:00 CST 2015, time=2015-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17520, encodeId=7f121e520d2, content=真不错,好像又有一点新的课题思路了, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhouanxiu, createdTime=Tue Mar 03 21:39:00 CST 2015, time=2015-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17516, encodeId=1a461e516d3, content=过高过低都不好, beContent=null, objectType=article, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Tue Mar 03 19:55:00 CST 2015, time=2015-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17513, encodeId=319f1e513c0, content=有趣, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f401615413, createdName=慧读, createdTime=Tue Mar 03 19:48:00 CST 2015, time=2015-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17514, encodeId=75501e514d8, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f401615413, createdName=慧读, createdTime=Tue Mar 03 19:48:00 CST 2015, time=2015-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17511, encodeId=cce61e51198, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Tue Mar 03 19:45:00 CST 2015, time=2015-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17512, encodeId=46a91e512e3, content=有价值, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Tue Mar 03 19:45:00 CST 2015, time=2015-03-03, status=1, ipAttribution=)]
    2015-04-13 yinhl1978
  2. [GetPortalCommentsPageByObjectIdResponse(id=1999508, encodeId=199e199950825, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Mon Apr 13 01:26:00 CST 2015, time=2015-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17520, encodeId=7f121e520d2, content=真不错,好像又有一点新的课题思路了, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhouanxiu, createdTime=Tue Mar 03 21:39:00 CST 2015, time=2015-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17516, encodeId=1a461e516d3, content=过高过低都不好, beContent=null, objectType=article, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Tue Mar 03 19:55:00 CST 2015, time=2015-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17513, encodeId=319f1e513c0, content=有趣, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f401615413, createdName=慧读, createdTime=Tue Mar 03 19:48:00 CST 2015, time=2015-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17514, encodeId=75501e514d8, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f401615413, createdName=慧读, createdTime=Tue Mar 03 19:48:00 CST 2015, time=2015-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17511, encodeId=cce61e51198, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Tue Mar 03 19:45:00 CST 2015, time=2015-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17512, encodeId=46a91e512e3, content=有价值, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Tue Mar 03 19:45:00 CST 2015, time=2015-03-03, status=1, ipAttribution=)]
    2015-03-03 zhouanxiu

    真不错,好像又有一点新的课题思路了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1999508, encodeId=199e199950825, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Mon Apr 13 01:26:00 CST 2015, time=2015-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17520, encodeId=7f121e520d2, content=真不错,好像又有一点新的课题思路了, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhouanxiu, createdTime=Tue Mar 03 21:39:00 CST 2015, time=2015-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17516, encodeId=1a461e516d3, content=过高过低都不好, beContent=null, objectType=article, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Tue Mar 03 19:55:00 CST 2015, time=2015-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17513, encodeId=319f1e513c0, content=有趣, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f401615413, createdName=慧读, createdTime=Tue Mar 03 19:48:00 CST 2015, time=2015-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17514, encodeId=75501e514d8, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f401615413, createdName=慧读, createdTime=Tue Mar 03 19:48:00 CST 2015, time=2015-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17511, encodeId=cce61e51198, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Tue Mar 03 19:45:00 CST 2015, time=2015-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17512, encodeId=46a91e512e3, content=有价值, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Tue Mar 03 19:45:00 CST 2015, time=2015-03-03, status=1, ipAttribution=)]
    2015-03-03 medcardio

    过高过低都不好

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1999508, encodeId=199e199950825, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Mon Apr 13 01:26:00 CST 2015, time=2015-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17520, encodeId=7f121e520d2, content=真不错,好像又有一点新的课题思路了, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhouanxiu, createdTime=Tue Mar 03 21:39:00 CST 2015, time=2015-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17516, encodeId=1a461e516d3, content=过高过低都不好, beContent=null, objectType=article, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Tue Mar 03 19:55:00 CST 2015, time=2015-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17513, encodeId=319f1e513c0, content=有趣, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f401615413, createdName=慧读, createdTime=Tue Mar 03 19:48:00 CST 2015, time=2015-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17514, encodeId=75501e514d8, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f401615413, createdName=慧读, createdTime=Tue Mar 03 19:48:00 CST 2015, time=2015-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17511, encodeId=cce61e51198, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Tue Mar 03 19:45:00 CST 2015, time=2015-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17512, encodeId=46a91e512e3, content=有价值, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Tue Mar 03 19:45:00 CST 2015, time=2015-03-03, status=1, ipAttribution=)]
    2015-03-03 慧读

    有趣

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1999508, encodeId=199e199950825, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Mon Apr 13 01:26:00 CST 2015, time=2015-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17520, encodeId=7f121e520d2, content=真不错,好像又有一点新的课题思路了, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhouanxiu, createdTime=Tue Mar 03 21:39:00 CST 2015, time=2015-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17516, encodeId=1a461e516d3, content=过高过低都不好, beContent=null, objectType=article, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Tue Mar 03 19:55:00 CST 2015, time=2015-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17513, encodeId=319f1e513c0, content=有趣, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f401615413, createdName=慧读, createdTime=Tue Mar 03 19:48:00 CST 2015, time=2015-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17514, encodeId=75501e514d8, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f401615413, createdName=慧读, createdTime=Tue Mar 03 19:48:00 CST 2015, time=2015-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17511, encodeId=cce61e51198, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Tue Mar 03 19:45:00 CST 2015, time=2015-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17512, encodeId=46a91e512e3, content=有价值, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Tue Mar 03 19:45:00 CST 2015, time=2015-03-03, status=1, ipAttribution=)]
    2015-03-03 慧读

    有意思

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1999508, encodeId=199e199950825, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Mon Apr 13 01:26:00 CST 2015, time=2015-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17520, encodeId=7f121e520d2, content=真不错,好像又有一点新的课题思路了, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhouanxiu, createdTime=Tue Mar 03 21:39:00 CST 2015, time=2015-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17516, encodeId=1a461e516d3, content=过高过低都不好, beContent=null, objectType=article, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Tue Mar 03 19:55:00 CST 2015, time=2015-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17513, encodeId=319f1e513c0, content=有趣, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f401615413, createdName=慧读, createdTime=Tue Mar 03 19:48:00 CST 2015, time=2015-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17514, encodeId=75501e514d8, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f401615413, createdName=慧读, createdTime=Tue Mar 03 19:48:00 CST 2015, time=2015-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17511, encodeId=cce61e51198, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Tue Mar 03 19:45:00 CST 2015, time=2015-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17512, encodeId=46a91e512e3, content=有价值, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Tue Mar 03 19:45:00 CST 2015, time=2015-03-03, status=1, ipAttribution=)]
    2015-03-03 MedSci客户端网友

    有意思

    0

  7. [GetPortalCommentsPageByObjectIdResponse(id=1999508, encodeId=199e199950825, content=<a href='/topic/show?id=d5df12695e6' target=_blank style='color:#2F92EE;'>#Neurol#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=12695, encryptionId=d5df12695e6, topicName=Neurol)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=8217292, createdName=yinhl1978, createdTime=Mon Apr 13 01:26:00 CST 2015, time=2015-04-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17520, encodeId=7f121e520d2, content=真不错,好像又有一点新的课题思路了, beContent=null, objectType=article, channel=null, level=null, likeNumber=113, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=zhouanxiu, createdTime=Tue Mar 03 21:39:00 CST 2015, time=2015-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17516, encodeId=1a461e516d3, content=过高过低都不好, beContent=null, objectType=article, channel=null, level=null, likeNumber=164, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=96871613250, createdName=medcardio, createdTime=Tue Mar 03 19:55:00 CST 2015, time=2015-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17513, encodeId=319f1e513c0, content=有趣, beContent=null, objectType=article, channel=null, level=null, likeNumber=102, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f401615413, createdName=慧读, createdTime=Tue Mar 03 19:48:00 CST 2015, time=2015-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17514, encodeId=75501e514d8, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=86, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=7f401615413, createdName=慧读, createdTime=Tue Mar 03 19:48:00 CST 2015, time=2015-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17511, encodeId=cce61e51198, content=有意思, beContent=null, objectType=article, channel=null, level=null, likeNumber=101, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Tue Mar 03 19:45:00 CST 2015, time=2015-03-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=17512, encodeId=46a91e512e3, content=有价值, beContent=null, objectType=article, channel=null, level=null, likeNumber=104, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=MedSci客户端网友, createdTime=Tue Mar 03 19:45:00 CST 2015, time=2015-03-03, status=1, ipAttribution=)]
    2015-03-03 MedSci客户端网友

    有价值

    0

相关资讯

如何才能解决医务人员睡眠问题

东南大学附属中大医院心理科近日对1000名医务人员调查发现,由于执业压力、医患纠纷等因素影响,高达六成的医务人员存在睡眠障碍。这不仅影响医务人员自身的健康,容易使其罹患一系列慢性疾病。也可能对医疗质量和医学发展产生影响。解决医务人员睡眠问题,提高医务人员睡眠质量,既需要医务人员自身的合理安排与调解,也需要社会的广泛关注.   警示:有睡眠障碍者高达6成中国医务人员的睡眠状况是非常糟糕的。据南京日

EJPC :睡眠充足可进一步降低心血管疾病风险

荷兰的一项基于人群的大型研究表明,除外4项传统的降低心血管事件风险的健康习惯(体育锻炼、健康饮食、戒烟和适当的饮酒)以外,每晚至少7小时的睡眠时间可进一步降低心血管疾病(CVD)事件风险。相关论文2013年7月2日发表于《欧洲预防心脏病学杂志》(European Journal of Preventive Cardiology )。 既往研究表明

睡眠时间≤5小时者易出现蛋白尿

    日本进行的一项研究显示,睡眠时间短(特别是≤5小时)是蛋白尿发生的预测指标。论文发表于《美国肾脏病杂志》(Am J Kidney Dis. 2012 Mar;59(3):343-55.)。     研究纳入在医疗中心进行年度体检且年龄在20~65岁的雇员6834名,其估计的肾小球滤过率(eGFR)不小于60 ml/(min·1.73 m

睡眠不规律将破坏上千基因严重损害健康

中新网1月22日电据新加坡《联合早报》22日报道,最新发表的研究表明,睡眠不规律会对超过1000个基因造成“严重破坏”,这可以解释为什么总上夜班、时差失调会导致一系列健康问题。 据报道,英国萨里大学的德克-扬·戴克教授等人通过室内光线亮度调节,让22名受试者的睡眠—清醒周期推迟4个小时,3天后这些受试者的睡眠出现在白天的中午,睡眠与清醒时间昼夜颠倒,但睡眠时间仍得到充分保证,并没有减少。

J Pediatr:睡眠不足导致青少年肥胖?

儿童和成人睡眠不足和肥胖与心血管代谢疾病有相关性。然而,这种关联在青少年身上还不明确。目前美国青少年超重和肥胖的发病率为30%,而青少年睡眠时间常常不够充足。近日J Pediatr发布的一项研究通过典型睡眠模式来预测肥胖青少年的心血管代谢疾病的发病风险。密西根和贝勒大学的Heidi B. IglayReger博士及其同事对37名肥胖青少年展开研究。通过测量空腹热量和血糖、腰围、BMI和血压,来计算

Neurology:老年人睡眠时间过长增加痴呆死亡率?

为了明确老年人睡眠时间过长是否与痴呆死亡率升高有关,来自西班牙马德里的Benito-León教授科研团队展开了相关研究,这一研究成果于近日发表在最新一期Neurology杂志上。 在本次前瞻性、以人群为基础的研究中,纳入了西班牙中部3857名未患痴呆症的65岁及以上的老年人,记录他们每天的睡眠时间。平均每日睡眠总时间分为三个等级:≤5小时 (短睡眠),6–8小时 (正常睡眠),≥9 小时